These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22849502)

  • 1. [Information for patients. Pancreatic cancer].
    A-Cienfuegos J; Rotellar F
    Rev Esp Enferm Dig; 2012 Jul; 104(7):385. PubMed ID: 22849502
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
    Loehrer AP; Ferrone CR
    Dig Surg; 2016; 33(4):343-50. PubMed ID: 27216011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer: An update on diagnosis and management.
    Loveday BPT; Lipton L; Thomson BN
    Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
    Kang CM; Hwang HK; Choi SH; Lee WJ
    Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What we have learned about pancreatic cancer from mouse models.
    Pérez-Mancera PA; Guerra C; Barbacid M; Tuveson DA
    Gastroenterology; 2012 May; 142(5):1079-92. PubMed ID: 22406637
    [No Abstract]   [Full Text] [Related]  

  • 9. Discussion.
    J Am Coll Surg; 2016 Apr; 222(4):456-8. PubMed ID: 27016973
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic Pancreatic Cancer.
    Hogendorf P; Durczyński A; Strzelczyk J
    J Invest Surg; 2018 Apr; 31(2):151-152. PubMed ID: 28267398
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings.
    Badiyan SN; Molitoris JK; Chuong MD; Regine WF; Kaiser A
    Surg Oncol Clin N Am; 2017 Jul; 26(3):431-453. PubMed ID: 28576181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Management of Pancreatic Cancer from an Internist Perspective.
    Sipra QUAR; Islam M; Riaz IB; Zhaohui J; Babiker HM; Bekaii-Saab TS; Sonbol MB
    Am J Med; 2021 May; 134(5):576-586. PubMed ID: 33316248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes.
    Kalimuthu SN; Serra S; Dhani N; Chetty R
    J Clin Pathol; 2016 Jun; 69(6):463-71. PubMed ID: 26915370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer.
    Eguchi H; Nagano H; Tanemura M; Takeda Y; Marubashi S; Kobayashi S; Kawamoto K; Wada H; Hama N; Akita H; Mori M; Doki Y
    Hepatogastroenterology; 2013 Jun; 60(124):904-11. PubMed ID: 23321032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of pancreatic cancer in the elderly - literature review.
    Gajda M; Kenig J
    Folia Med Cracov; 2018; 58(3):49-66. PubMed ID: 30521511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
    Loehrer AP; Kinnier CV; Ferrone CR
    Adv Surg; 2016 Sep; 50(1):115-28. PubMed ID: 27520867
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant treatment for pancreatic ductal carcinoma.
    Macarulla T; Fernández T; Gallardo ME; Hernando O; López AM; Hidalgo M
    Clin Transl Oncol; 2017 Oct; 19(10):1199-1204. PubMed ID: 28639051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
    Boone BA; Zenati MS; Rieser C; Hamad A; Al-Abbas A; Zureikat AH; Hogg ME; Neal MD; Zeh HJ
    Ann Surg Oncol; 2019 May; 26(5):1503-1511. PubMed ID: 30652227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
    Kawaida H; Fujii H
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.
    Jaseanchiun W; Kato H; Hayasaki A; Fujii T; Iizawa Y; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    Pancreatology; 2019 Mar; 19(2):307-315. PubMed ID: 30738764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.